Case Timeline Item
Amgen, Inc. and Horizon Therapeutics plc, In the Matter of (timeline item) - July 25, 2023
Date
File
Displaying 3101 - 3120 of 39041
July 25, 2023
Case Timeline Item
Intercontinental Exchange, Inc./Black Knight, Inc., In the Matter of (timeline item) - July 25, 2023
Date
File
Order Withdrawing This Matter from Adjudication
(107.71 KB)
July 24, 2023
Case Timeline Item
IQVIA Holdings/Propel Media, In the Matter of (timeline item) - July 24, 2023
Date
File
File
File
File
File
File
File
File
File
File
File
File
File
July 21, 2023
Case Timeline Item
Amgen, Inc. and Horizon Therapeutics plc, In the Matter of (timeline item) - July 21, 2023
Date
File
File
July 20, 2023
Statement of Chair Lina M. Khan Regarding the Policy Statement Concerning Reliance on Prior PBM-Related Advocacy Statements and Reports
Date
By
Lina M. Khan, Former Chair and Commissioner
FTC Votes to Issue Statement Withdrawing Prior Pharmacy Benefit Manager Advocacy
Date
The Federal Trade Commission voted to issue a statement cautioning against reliance on prior advocacy statements and studies related to pharmacy benefit mangers (PBMs) that no longer reflect current...
FTC and HHS Warn Hospital Systems and Telehealth Providers about Privacy and Security Risks from Online Tracking Technologies
Date
The Federal Trade Commission and the U.S. Department of Health and Human Services' Office for Civil Rights (OCR) are cautioning hospitals and telehealth providers about the privacy and security risks...
Case Timeline Item
Microsoft/Activision Blizzard, In the Matter of (timeline item) - July 20, 2023
Date
File
Order Withdrawing Matter from Adjudication
(115.08 KB)
July 19, 2023
Statement Of Commissioner Rebecca Kelly Slaughter Joined by Chair Lina M. Khan and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
P234000
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines
Date
By
Lina M. Khan, Former Chair and Commissioner
Matter Number
P234000
FTC Takes Action Against Makers of Sobrenix Supplement That Deceptively Claimed to Reduce Alcohol Cravings, Relied on Fake Endorsements
Date
The Federal Trade Commission is taking action under the FTC Act and the Opioid Addiction Recovery Fraud Prevention Act of 2018 (OARFPA) against the makers of Sobrenix, which was marketed to reduce and...
FTC Seeks Comment on New Parental Consent Mechanism Under COPPA
Date
The Federal Trade Commission is seeking comment on an application from the Entertainment Software Rating Board (ESRB) and others for a new mechanism for obtaining parental consent under the Children’s...
FTC and DOJ Seek Comment on Draft Merger Guidelines
Date
Today, the Federal Trade Commission and the Department of Justice are releasing a draft update of the Merger Guidelines, which describe and guide the agencies’ review of mergers and acquisitions to...
Case Timeline Item
Amgen, Inc. and Horizon Therapeutics plc, In the Matter of (timeline item) - July 19, 2023
Date
File
Scheduling Order
(795.28 KB)
Displaying 3101 - 3120 of 39041